In 2024, childhood tuberculosis will still be a significant global public health issue, especially in underdeveloped nations (LMICS). It is true that the underestimation of the disease's extent and its quick progression towards the stage of illness, sometimes involving severe manifestations, stem from the challenges associated with diagnosis in this age range. It is crucial to remember that none of the different TB solutions implemented have made the child the primary focus. The child's TB situation is getting more and more problematic due to the HIV/AIDS positive status and antibiotic resistance. Access to care can be challenging in some areas. Given that the affected population has recently been exposed to M. tuberculosis, it is imperative that greater attention be paid to this pediatric variant.
Over time, other types of pediatric ratings—clinical scores in particular—have been offered by writers to help diagnose tuberculosis in nations with limited resources. Large-scale validation of the results was not possible due to their intense controversy.
Most pediatric cases of tuberculosis are found by screening around an index case. Most of the time, it is a diagnosis made after a number of debates. Currently, there is no reliable gold standard for identifying tuberculosis in children, particularly the youngest members of the population, which
results in a decline in the likelihood of diagnosis and treatment, as well as a rise in morbidity and death in this age range. Therefore, it is intriguing to establish a trustworthy system of standardized scores that will enable the early detection of tuberculosis infection and disease cases so that prompt treatment can be provided. Aside from its medical benefits, this technology will also save money by decreasing the need for traditional bacteriological confirmation techniques, which are less accurate because pediatric tuberculosis is uncommon and collecting respiratory samples can be challenging, particularly from the youngest children.